{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:36:47Z","timestamp":1791319007910,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T00:00:00Z","timestamp":1247097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>The persistence of circulating tumor cells (CTC) in breast cancer patients might be associated with stem cell like tumor cells which have been suggested to be the active source of metastatic spread in primary tumors. Furthermore, these cells also may undergo phenotypic changes, known as epithelial-mesenchymal transition (EMT), which allows them to travel to the site of metastasis formation without getting affected by conventional treatment. Here we evaluated 226 blood samples of 39 metastatic breast cancer patients during a follow-up of palliative chemo-, antibody \u2013 or hormonal therapy for the expression of the stem cell marker ALDH1 and markers for EMT and correlated these findings with the presence of CTC and response to therapy.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>2 \u00d7 5 ml blood was analyzed for CTC with the <jats:italic>AdnaTest BreastCancer<\/jats:italic> (AdnaGen AG) for the detection of EpCAM, MUC-1 and HER2 transcripts. The recovered c-DNA was additionally multiplex tested for three EMT markers [Twist1, Akt2, PI3K\u03b1] and separately for the tumor stem-cell markers ALDH1. The identification of EMT markers was considered positive if at least one marker was detected in the sample.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>97% of 30 healthy donor samples investigated were negative for EMT and 95% for ALDH1 transcripts. CTC were detected in 69\/226 (31%) cancer samples. In the CTC (+) group, 62% were positive for at least one of the EMT markers and 69% for ALDH1, respectively. In the CTC (-) group the percentages were 7% and 14%, respectively. In non-responders, EMT and ALDH1 expression was found in 62% and 44% of patients, in responders the rates were 10% and 5%, respectively.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Our data indicate that a major proportion of CTC of metastatic breast cancer patients shows EMT and tumor stem cell characteristics. Further studies are needed to prove whether these markers might serve as an indicator for therapy resistant tumor cell populations and, therefore, an inferior prognosis.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr2333","type":"journal-article","created":{"date-parts":[[2009,7,9]],"date-time":"2009-07-09T18:13:40Z","timestamp":1247163220000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":636,"title":["Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients"],"prefix":"10.1186","volume":"11","author":[{"given":"Bahriye","family":"Aktas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Tewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Fehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Hauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kasimir-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,9]]},"reference":[{"key":"2297_CR1","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrc2375","volume":"8","author":"K Pantel","year":"2008","unstructured":"Pantel K, Brakenhoff RH, Brandt B: Detection, clinical relevance and specific biological properties of disseminating tumor cells. Nat Rev Cancer. 2008, 8: 329-340. 10.1038\/nrc2375.","journal-title":"Nat Rev Cancer"},{"key":"2297_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y Husemann","year":"2008","unstructured":"Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, Forni G, Eils R, Fehm T, Riethmuller G, Klein CA: Systemic spread is an early step in breast cancer. Cancer Cell. 2008, 13: 58-68. 10.1016\/j.ccr.2007.12.003.","journal-title":"Cancer Cell"},{"key":"2297_CR3","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"S Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber G, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon A, Pantel K: A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005, 353: 793-802. 10.1056\/NEJMoa050434.","journal-title":"N Engl J Med"},{"key":"2297_CR4","first-page":"1582","volume":"7","author":"S Kasimir-Bauer","year":"2001","unstructured":"Kasimir-Bauer S, Mayer S, Bojko P, Borquez D, Neumann R, Seeber S: Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy. Clin Cancer Res. 2001, 7: 1582-1588.","journal-title":"Clin Cancer Res"},{"key":"2297_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1200\/JCO.2000.18.1.80","volume":"18","author":"S Braun","year":"2000","unstructured":"Braun S, Kentenich C, Janni W, Hepp F, de Waal J, Willgeroth F, Sommer H, Pantel K: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol. 2000, 18: 80-86.","journal-title":"J Clin Oncol"},{"key":"2297_CR6","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1158\/1078-0432.CCR-04-0245","volume":"10","author":"G Wiedswang","year":"2004","unstructured":"Wiedswang G, Borgen E, Karesen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B: Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome. Clin Cancer Res. 2004, 10: 5342-5348. 10.1158\/1078-0432.CCR-04-0245.","journal-title":"Clin Cancer Res"},{"key":"2297_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10549-005-9095-6","volume":"97","author":"S Becker","year":"2006","unstructured":"Becker S, Becker-Pergola G, Wallwiener D, Becker , Becker-Pergola G, Wallwiener D, Solomayer EF, Fehm T: Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy. Breast Cancer Res Treat. 2006, 97: 91-96. 10.1007\/s10549-005-9095-6.","journal-title":"Breast Cancer Res Treat"},{"key":"2297_CR8","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1158\/1078-0432.CCR-06-1537","volume":"12","author":"MS Wicha","year":"2006","unstructured":"Wicha MS: Cancer stem cells and metastasis: lethal seeds. Clin Cancer Res. 2006, 12: 5606-5607. 10.1158\/1078-0432.CCR-06-1537.","journal-title":"Clin Cancer Res"},{"key":"2297_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008, 8: 755-768. 10.1038\/nrc2499.","journal-title":"Nat Rev Cancer"},{"key":"2297_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000123845","volume":"75","author":"E Charafe-Jauffret","year":"2008","unstructured":"Charafe-Jauffret E, Monville F, Ginestier C, Dontu G, Birnbaum D, Wicha MS: Cancer stem cells in breast: current opinion and future challenges. Pathobiology. 2008, 75: 75-84. 10.1159\/000123845.","journal-title":"Pathobiology"},{"key":"2297_CR11","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.1158\/1078-0432.CCR-06-0169","volume":"12","author":"M Balic","year":"2006","unstructured":"Balic M, Lin H, Young L, Hawes D, Giuliano A, McNamara G, Datar RH, Cote RJ: Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clin Cancer Res. 2006, 12: 5615-5621. 10.1158\/1078-0432.CCR-06-0169.","journal-title":"Clin Cancer Res"},{"key":"2297_CR12","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1158\/1078-0432.1154.11.3","volume":"11","author":"BK Abraham","year":"2005","unstructured":"Abraham BK, Fritz P, McClellan M, Hauptvogel P, Athelogou M, Brauch H: Prevalence of CD44+\/CD24-\/low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis. Clin Cancer Res. 2005, 11: 1154-1159.","journal-title":"Clin Cancer Res"},{"key":"2297_CR13","first-page":"143","volume":"1","author":"NA Sophos","year":"2003","unstructured":"Sophos NA, Vasiliou V: Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem Biol Interact. 2003, 1: 143-144.","journal-title":"Chem Biol Interact"},{"key":"2297_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002, 2: 442-454. 10.1038\/nrc822.","journal-title":"Nat Rev Cancer"},{"key":"2297_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader JE, Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 2008, 8: 755-768. 10.1038\/nrc2499.","journal-title":"Nat Rev Cancer"},{"key":"2297_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","volume":"118","author":"Y Kang","year":"2004","unstructured":"Kang Y, Massague J: Epithelial-mesenchymal transitions: TWIST in development and metastasis. Cell. 2004, 118: 277-279. 10.1016\/j.cell.2004.07.011.","journal-title":"Cell"},{"key":"2297_CR17","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.1158\/1078-0432.CCR-07-0024","volume":"13","author":"MA Watson","year":"2007","unstructured":"Watson MA, Ylagan LR, Trinkaus KM, Gillanders WE, Naughton MJ, Weilbaecher KN, Fleming TP, Aft RL: Isolation and molecular profiling of bone marrow micrometastases identifies TWIST1 as a marker of early tumor relapse in breast cancer patients. Clin Cancer Res. 2007, 13: 5001-5009. 10.1158\/1078-0432.CCR-07-0024.","journal-title":"Clin Cancer Res"},{"key":"2297_CR18","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1158\/0008-5472.CAN-06-1479","volume":"67","author":"GZ Cheng","year":"2007","unstructured":"Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH: TWIST transcriptionally up-regulates Akt2 in breast cancer cells leading to increased migration, invasion and resistance to paclitaxel. Cancer Res. 2007, 67: 1979-1987. 10.1158\/0008-5472.CAN-06-1479.","journal-title":"Cancer Res"},{"key":"2297_CR19","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1242\/jcs.114.8.1439","volume":"114","author":"DA Cantrell","year":"2001","unstructured":"Cantrell DA: Phosphoinositide 3-kinase signalling pathways. J Cell Sci. 2001, 114: 1439-1445.","journal-title":"J Cell Sci"},{"key":"2297_CR20","doi-asserted-by":"publisher","first-page":"772","DOI":"10.4161\/cbt.3.8.994","volume":"3","author":"KE Bachman","year":"2004","unstructured":"Bachman KE, Argani P, Samuels Y, Silliman N, Ptak J, Szabo S, Konishi H, Karakas B, Blair BG, Lin C, Peters BA, Velculescu VE, Park BH: The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther. 2004, 3: 772-775.","journal-title":"Cancer Biol Ther"},{"key":"2297_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/bcr739","volume":"6","author":"NM Chau","year":"2004","unstructured":"Chau NM, Ashcroft M: Akt2: a role in breast cancer metastasis. Breast Cancer Res. 2004, 6: 55-57. 10.1186\/bcr739.","journal-title":"Breast Cancer Res"},{"key":"2297_CR22","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1124\/mol.106.023333","volume":"70","author":"K Liang","year":"2006","unstructured":"Liang K, Lu Y, Li X, Zeng X, Glazer RI, Mills GB, Fan Z: Differential roles of phosphoinositide-dependent protein kinase-1 and akt1 expression and phosphorylation in breast cancer cell resistance to paclitaxel, doxorubicin, and gemcitabine. Mol Pharmacol. 2006, 70: 1045-1052. 10.1124\/mol.106.023333.","journal-title":"Mol Pharmacol"},{"key":"2297_CR23","first-page":"13","volume-title":"World Health Organization classification of tumours: tumours of the breast and female genital organs","author":"IO Ellis","year":"2003","unstructured":"Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA: Invasive breast carcinoma. World Health Organization classification of tumours: tumours of the breast and female genital organs. Edited by: Tavassoli FA, Devilee P. 2003, Lyon: IARC Press, 13-59."},{"key":"2297_CR24","volume-title":"TNM classification of malignant tumours","author":"LH Sobin","year":"2002","unstructured":"Sobin LH, Wittekind C: International Union against Cancer. TNM classification of malignant tumours. 2002, New York: Wiley-Liss, 6","edition":"6"},{"key":"2297_CR25","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1309\/VE7862V2646BR6EX","volume":"121","author":"P Lal","year":"2004","unstructured":"Lal P, Salazar PA, Hudis CA, Ladanyi M, Chen B: HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring. Am J Clin Pathol. 2004, 121: 631-636. 10.1309\/VE7862V2646BR6EX.","journal-title":"Am J Clin Pathol"},{"key":"2297_CR26","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003, 100: 3547-3549. 10.1073\/pnas.0530291100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2297_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa063994","volume":"356","author":"R Liu","year":"2007","unstructured":"Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med. 2007, 356: 217-226. 10.1056\/NEJMoa063994.","journal-title":"N Engl J Med"},{"key":"2297_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007, 1: 555-567. 10.1016\/j.stem.2007.08.014.","journal-title":"Cell Stem Cell"},{"key":"2297_CR29","first-page":"452","volume":"49","author":"PA Theodoropoulos","year":"2008","unstructured":"Theodoropoulos PA, Polioudaki H, Sanidas E, Agelaki S, Mavroudis D, Georgoulias V: Detection of circulating tumor cells with breast cancer stem cell-like phenotype in blood samples of patients with breast cancer. Proc Am Assoc Cancer Res. 2008, 49: 452-","journal-title":"Proc Am Assoc Cancer Res"},{"key":"2297_CR30","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-008-0143-x","volume":"115","author":"M Tewes","year":"2009","unstructured":"Tewes M, Aktas B, Welt A, Mueller S, Hauch S, Kimmig R, Kasimir-Bauer S: Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treat. 2009, 115: 581-590. 10.1007\/s10549-008-0143-x.","journal-title":"Breast Cancer Res Treat"},{"key":"2297_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ccr.2007.01.013","volume":"11","author":"M Shipitsin","year":"2007","unstructured":"Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K: Molecular definition of breast tumor heterogeneity. Cancer Cell. 2007, 11: 259-273. 10.1016\/j.ccr.2007.01.013.","journal-title":"Cancer Cell"},{"key":"2297_CR32","doi-asserted-by":"publisher","first-page":"R4","DOI":"10.1186\/bcr1636","volume":"9","author":"LG Fulford","year":"2007","unstructured":"Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, Easton D, Lakhani SR: Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival. Breast Cancer Res. 2007, 9: R4-10.1186\/bcr1636.","journal-title":"Breast Cancer Res"},{"key":"2297_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12015-007-0020-8","volume":"3","author":"K Polyak","year":"2007","unstructured":"Polyak K: Breast cancer stem cells: a case of mistaken identity?. Stem Cell Rev. 2007, 3: 107-109. 10.1007\/s12015-007-0020-8.","journal-title":"Stem Cell Rev"},{"key":"2297_CR34","volume-title":"Proceedings of the American Association of Cancer Research 12\u201316 April 2008; San Diego, CA","author":"H Korkaya","year":"2012","unstructured":"Korkaya H, Paulson A, Iovino F, Wicha M: HER2 regulates the normal and malignant mammary stem\/progenitor cell population that drives tumorigenesis and invasion. Proceedings of the American Association of Cancer Research 12\u201316 April 2008; San Diego, CA. 2012"},{"key":"2297_CR35","doi-asserted-by":"publisher","first-page":"10069","DOI":"10.1073\/pnas.0703900104","volume":"104","author":"SA Mani","year":"2007","unstructured":"Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL, Weinberg RA: Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA. 2007, 104: 10069-10074. 10.1073\/pnas.0703900104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2297_CR36","doi-asserted-by":"publisher","first-page":"R76","DOI":"10.1186\/bcr2143","volume":"10","author":"T Fehm","year":"2008","unstructured":"Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, D\u00fcrr-St\u00f6rzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S: ER\u03b1-status of disseminated tumor cells in bone marrow of primary breast cancer patients. Breast Cancer Res. 2008, 10: R76-10.1186\/bcr2143.","journal-title":"Breast Cancer Res"},{"key":"2297_CR37","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/bcr1783","volume":"9","author":"T Fehm","year":"2007","unstructured":"Fehm T, Becker S, Duerr-Stoerzer S, Sotlar K, Mueller V, Wallwiener D, Lane N, Solomayer E, Uhr J: Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status. Breast Cancer Res. 2007, 9: R74-10.1186\/bcr1783.","journal-title":"Breast Cancer Res"},{"key":"2297_CR38","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/bcr2149","volume":"10","author":"G Kallergi","year":"2008","unstructured":"Kallergi G, Agelaki S, Kalykaki A, Stournaras C, Mavroudis D, Georgoulias V: Phosphorylated EGFR and PI3K\/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients. Breast Cancer Res. 2008, 10: R80-10.1186\/bcr2149.","journal-title":"Breast Cancer Res"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr2333\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr2333.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:51:46Z","timestamp":1728384706000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr2333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,9]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,8]]}},"alternative-id":["2297"],"URL":"https:\/\/doi.org\/10.1186\/bcr2333","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,9]]},"assertion":[{"value":"7 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R46"}}